Bandingkan Harga & Kinerja Midi Utama Indonesia Tbk. (MIDI) vs Tempo Scan Pacific Tbk. (TSPC)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Midi Utama Indonesia Tbk. dan Tempo Scan Pacific Tbk.: Midi Utama Indonesia Tbk. diperdagangkan di Rp282 (kapitalisasi pasar 9,5 T, volume 24 jam 1,62 jt), sedangkan Tempo Scan Pacific Tbk. diperdagangkan di Rp2.590 (kapitalisasi pasar 11,36 T, volume 24 jam 1,77 jt). Perbedaan utamanya: Tempo Scan Pacific Tbk. lebih besar dari sisi kapitalisasi pasar, dan Tempo Scan Pacific Tbk. lebih aktif diperdagangkan (1,77 jt vs 1,62 jt). Mana yang lebih baik tergantung tujuan investasimu.
| MIDI | TSPC | |
|---|---|---|
Kapitalisasi Pasar | 9,5 T | 11,36 T |
Volume | 1,62 jt | 1,77 jt |
Lot | 16,19 rb | 17,71 rb |
Perputaran | 454,66 jt | 4,61 M |
Harga Rata-rata | 280,76 | 2.603,9 |
Nilai Transaksi | 454,66 jt | 4,61 M |
Harga Ekuilibrium Indikatif | 282 | 2.590 |
Volume Ekuilibrium Indikatif | 803 | 300 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Midi Utama Indonesia Tbk.
PT Midi Utama Indonesia (the company) was established under its original name of PT Midimart Utama base on notarial deed No.37 of Mr Frans Elsius, S.H, dated on 28 Jun, 2007. The Company’s articles of association has been amended several times, most recently by notarial deed No. 2 of Kamelina, S.H., dated Mar 3, 2010, concerning among others, increase in capital paid up and public offering.
Selengkapnya di halaman MIDI →Tentang Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Selengkapnya di halaman TSPC →
